The levonorgestrel-releasing intrauterine system: Its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids

Gynecological Endocrinology

Volumn 29, Issue 5, 2013, Pages 492-495

  MacHado, Rogério Bonassi ^a   De Souza, Isadora Matias ^a   Beltrame, Amanda ^a   Bernardes, Carine Rejane ^a   Morimoto, Mariana Spagnuolo ^a   Santana, Narayana ^a  

^a School of Physical Education of Jundiaí   (Brazil)

Author keywords

Bleeding; Levonorgestrel releasing intrauterine system; Menorrhagia; Perimenopause; Uterine fibroids

Indexed keywords

HEMOGLOBIN; LEVONORGESTREL;

ABDOMINAL PAIN; ADULT; ARTICLE; BLADDER INJURY; CLIMACTERIUM; CLINICAL ARTICLE; COHORT ANALYSIS; ECHOGRAPHY; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYSTERECTOMY; LONGITUDINAL STUDY; MOOD CHANGE; OBSERVATIONAL STUDY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY ANALYSIS; UTERUS BLEEDING; UTERUS MYOMA; VAGINAL DRYNESS;

ADULT; FEMALE; HUMANS; HYSTERECTOMY; INTRAUTERINE DEVICES, MEDICATED; LEIOMYOMA; LEVONORGESTREL; LONGITUDINAL STUDIES; MIDDLE AGED; PATIENT SATISFACTION; PERIMENOPAUSE; PROSPECTIVE STUDIES; UTERINE HEMORRHAGE; UTERINE NEOPLASMS;

EID: 84875872737     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.769517     Document Type: Article

References (14)

1. Fernandez H, Farrugia M, Jones SE, et al. Rate, type, and cost of invasive interventions for uterine myomas in Germany, France, and England. J Minim Invasive Gynecol 2009;16:40-6.
2. Nishizawa S, Inubushi M, Kido A, et al. Incidence and characteristics of uterine leiomyomas with FDG uptake. Ann Nucl Med 2008;22:803-10.
3. Maia Jr H, Pimentel K, Casoy J, et al. Aromatase expression in the eutopic endometrium of myomatous uteri: the influence of the menstrual cycle and oral contraceptive use. Gynecol Endocrinol 2007;23:320-4. (Pubitemid 47038253)
4. Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008;198:e1-7.
5. Tuppurainen M, Honkanen R, Kro?ger H, et al. Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women - the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas 1993;17:89-100.
6. Santoro N, Randolph Jr JF. Reproductive hormones and the menopause transition. Obstet Gynecol Clin North Am 2011;38:455-66.
7. Rose S, Chaudhari A, Peterson CM. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception. Adv Drug Deliv Rev 2009;61:808-12.
8. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-72. (Pubitemid 34002968)
9. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
10. Peddada SD, Laughlin SK, Miner K, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci USA 2008;105:19887-92.
11. Hurskainen R, Teperi J, Rissanen P, et al. Quality of life and costeffectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357:273-7. (Pubitemid 32120860)
12. Gon? i AZ, Lacruz RL, Paricio JJ, Herna'ndez Rivas FJ. The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia. Gynecol Endocrinol 2009;25:581-6.
13. Grigorieva V, Chen-Mok M, Tarasova M, Mikhailov A. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003;79:1194-8. (Pubitemid 36547859)
14. Magalha?es J, Aldrighi JM, de Lima GR. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 2007;75:193-8. (Pubitemid 46237609)